We have over 12,000 students, from over 100 countries, within one of the safest campuses in the UK


97% of Lancaster students go into work or further study within six months of graduating

Home > Research > Publications & Outputs > Genotyping the future
View graph of relations

« Back

Genotyping the future: scientists' expectations about race/ethnicity after BiDil

Research output: Contribution to journalJournal article


  • Richard Tutton
  • Andrew Smart
  • Paul A. Martin
  • Richard Ashcroft
  • George T. H. Ellison
<mark>Journal publication date</mark>09/2008
<mark>Journal</mark>Journal of Law, Medicine and Ethics
Number of pages7
<mark>Original language</mark>English


The ongoing debate about the FDA approval of BiDil in 2005 demonstrates how the first racially/ethnically licensed drug is entangled in both Utopian and dystopian future visions about the continued saliency of race/ethnicity in science and medicine. Drawing on the sociology of expectations, this paper analyzes how scientists in the field of pharmacogenetics are constructing certain visions of the future with respect to the use of social categories of race/ethnicity and the impact of high-throughput genotyping technologies that promise to transform scientific practices.